Dare Bioscience (DARE) Net Margin (QoQ) (2014 - 2025)
Analysis
Dare Bioscience (DARE) Net Margin (QoQ) (2014 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.86 Bn | 192.87 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.52 Bn | 176.34 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.47 Bn | 123.62 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.16 Bn | 55.98 Bn | 1.37 Bn |
| 6 | Moderna | 53.15 Bn | 48.02 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.20 Bn | 29.89 Bn | 992.69 Mn |
| 8 | Biogen | 31.65 Bn | 30.37 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.30 Bn | 29.30 Bn | 1.16 Mn |
| 10 | Dare Bioscience | 10.57 Mn | -2.05 Mn | -132,343.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 16.22 Mn |
| Sep 30, 2025 | -18.04 Mn |
| Jun 30, 2025 | 3.60 Mn |
| Mar 31, 2025 | -2.64 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 3.32 Mn |
| Mar 31, 2024 | -6.56 Mn |
| Dec 31, 2023 | 34,524.00 |
| Jun 30, 2017 | 1,167.00 |
| Mar 31, 2017 | -158.00 |
| Jun 30, 2014 | -1.62 Mn |